Spyre Therapeutics, Inc.SYRENASDAQ
Loading
P/E Ratio: Discounted ValuationCompressed
Percentile Rank0
Studio
Year-over-Year Change

Price-to-earnings ratio

Latest
-73.04
↓ 625% vs avg
Percentile
P0
Near historical low
Streak
2 yr
Consecutive declineCompressed
Average
-10.07
Historical baseline
PeriodValueYoY Change
2025-73.04-1287.8%
2024-5.26-1101.3%
2023-0.44+3.2%
2022-0.45+90.5%
2021-4.75+8.6%
2020-5.19-66.5%
2019-3.12+11.3%
2018-3.52-17.0%
2017-3.00-53.1%
2016-1.96-